Login

Ben McMillan, CIO and founder of IDX Digital Assets, discusses market insights in an interview with CNBC. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Focuses on early-stage growth software and data-center investments|Ping Li,Partner,Accel
00:10:00
IAMGOLD's President and CEO, Gord Stothert, Highlights Company's Growth and Operational Strategy at 121 Mining Investment EMEA
00:10:00
Altech Chemicals: Pioneering High Purity Alumina for LED and Lithium Battery Innovations
00:10:00
Market Turbulence: Insights from Emin Baghramyan on Low Volatility Investing | Lead Portfolio Manager, TD Asset Management
00:10:00
RNC Minerals' Impressive Growth and Recent Achievements Highlighted in Interview
00:10:00
"Howard Marks on Oaktree Capital's Investment Philosophy and Future Outlook: An In-Depth Discussion on Asset TV"
00:10:00
Understanding the 72(q)/72(t) Early Distribution Method | Dylan Potter - VICE PRESIDENT, WEALTH MANAGER of Howe & Rusling, Inc.
00:10:00
Mental Health in the Fast-Paced Financial Sector | Paul Feeney, CEO , Quilter Plc .
00:10:00
The Power of Financial Planning | Morgan Ranstrom - Partner & Lead Financial Planner , Financial Map Maker of Trailhead Planners, LLC
00:10:00
Navigating the Future of Energy: Rhett Bennett on Black Mountain's Expansion and the Critical Role of Nickel | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
Plancorp's 30 Years of Success in Structured Investment Portfolios | Jeff Buckner, Chairman, Plancorp LLC.
00:10:00
Adapting to Changing Tides Insights from abrdn Property Income Trust's Q2 Performance and Strategy,CEO,abrdn Property Income Trust Limited

© 2017 - Neuhu+